In Vitro Interactions of Antifungal Agents and Everolimus Against Aspergillus Species
Multiple cellular activities, including protein and lipid synthesis, ribosome biogenesis, and metabolic processes, are regulated by the target of rapamycin (TOR) pathway. Recent research suggests that the TOR might play an important role in various physiological functions of pathogenic fungi, such a...
Main Authors: | Huiping Jiang, Jianqun Xiong, Lihua Tan, Ping Jin, Yi Sun, Lianjuan Yang, Jingwen Tan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-07-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2022.936814/full |
Similar Items
-
Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities
by: Julio Pascual, et al.
Published: (2017-05-01) -
Interactions between antifungals and everolimus against Cryptococcus neoformans
by: Pin Liang, et al.
Published: (2023-03-01) -
The Synergistic Effect of Tacrolimus (FK506) or Everolimus and Azoles Against Scedosporium and Lomentospora Species In Vivo and In Vitro
by: Zikuo Wang, et al.
Published: (2022-04-01) -
Evaluation of Everolimus Activity against <i>Mycobacterium tuberculosis</i> Using In Vitro Models of Infection
by: Delia Mercedes Bianco, et al.
Published: (2023-01-01) -
Upregulation of Peroxiredoxin-2 in Well-Differentiated Pancreatic Neuroendocrine Tumors and Its Utility as a Biomarker for Predicting the Response to Everolimus
by: Eui Joo Kim, et al.
Published: (2020-11-01)